Friday, May 1, 2026

Trump’s Speech Triggers Market Turmoil: What Asian Investors Need to Know

U.S. markets showed volatility after Trump's speech, with KOSPI and KOSDAQ indices declining amid concerns over Iran and oil prices.

CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS

CGBio's DCLASSY PDRN skin booster gains IDE approval for clinical trials targeting eye wrinkles, enhancing patient satisfaction and market competitiveness.

South Korea Considers Individual Tourism to North Korea Despite Tensions

South Korea considers individual tourism to North Korea to ease tensions, despite challenges and UN sanctions.

Tag: FDA decisions

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

Top News

- Our Sponsors Ad -

Follow us